News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
773,161 Results
Type
Article (76703)
Company Profile (383)
Press Release (696075)
Section
Business (216022)
Career Advice (3286)
Deals (37164)
Drug Delivery (117)
Drug Development (87030)
Employer Resources (183)
FDA (17551)
Job Trends (16213)
News (368969)
Policy (36181)
Tag
2024 BioCapital Digital (16)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (13)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (6)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (15)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2959)
Academic (2)
Accelerated approval (3)
Adcomms (26)
Allergies (82)
Alliances (55034)
ALS (82)
Alzheimer's disease (1428)
Antibody-drug conjugate (ADC) (127)
Approvals (17507)
Artificial intelligence (247)
Autoimmune disease (13)
Automation (14)
Bankruptcy (372)
Best Places to Work (12297)
BIOSECURE Act (20)
Biosimilars (100)
Biotechnology (265)
Bladder cancer (55)
Brain cancer (27)
Breast cancer (248)
Cancer (1904)
Cardiovascular disease (153)
Career advice (2775)
Career pathing (32)
CAR-T (146)
Cell therapy (422)
Cervical cancer (15)
Clinical research (69520)
Collaboration (755)
Compensation (375)
Complete response letters (29)
COVID-19 (2831)
CRISPR (38)
C-suite (188)
Cystic fibrosis (104)
Data (1747)
Decentralized trials (2)
Denatured (40)
Depression (47)
Diabetes (240)
Diagnostics (6655)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (114)
Drug pricing (114)
Drug shortages (29)
Duchenne muscular dystrophy (68)
Earnings (85225)
Editorial (34)
Employer branding (24)
Employer resources (158)
Events (116534)
Executive appointments (626)
FDA (18559)
Featured Employer (68)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (675)
Gene editing (96)
Generative AI (27)
Gene therapy (296)
GLP-1 (768)
Government (4847)
Grass and pollen (4)
Guidances (43)
Healthcare (20108)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (102)
Indications (24)
Infectious disease (2963)
Inflammatory bowel disease (137)
Inflation Reduction Act (11)
Influenza (47)
Intellectual property (73)
Interviews (612)
IPO (17007)
IRA (46)
Job creations (4393)
Job search strategy (2309)
Kidney cancer (10)
Labor market (26)
Layoffs (494)
Leadership (19)
Legal (8676)
Liver cancer (72)
Lung cancer (277)
Lymphoma (124)
Machine learning (2)
Management (62)
Manufacturing (271)
MASH (60)
Medical device (14033)
Medtech (14038)
Mergers & acquisitions (20562)
Metabolic disorders (644)
Multiple sclerosis (65)
NASH (22)
Neurodegenerative disease (88)
Neuropsychiatric disorders (28)
Neuroscience (1906)
NextGen: Class of 2025 (7258)
Non-profit (4943)
Northern California (2214)
Now hiring (33)
Obesity (354)
Opinion (260)
Ovarian cancer (63)
Pain (79)
Pancreatic cancer (70)
Parkinson's disease (125)
Partnered (19)
Patents (189)
Patient recruitment (82)
Peanut (50)
People (61686)
Pharmaceutical (92)
Pharmacy benefit managers (20)
Phase I (21575)
Phase II (30337)
Phase III (22781)
Pipeline (832)
Podcasts (106)
Policy (115)
Postmarket research (3156)
Preclinical (9712)
Press Release (72)
Prostate cancer (89)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (369)
Real estate (6739)
Recruiting (73)
Regulatory (24618)
Reports (43)
Research institute (2632)
Resumes & cover letters (518)
Rett syndrome (2)
RNA editing (1)
RSV (44)
Schizophrenia (70)
Series A (123)
Series B (73)
Service/supplier (16)
Sickle cell disease (53)
Southern California (1918)
Special edition (17)
Sponsored (33)
Startups (4021)
State (2)
Stomach cancer (13)
Supply chain (62)
The Weekly (65)
United States (20086)
Vaccines (724)
Venture capitalists (35)
Webinars (13)
Weight loss (264)
Women's health (34)
Worklife (16)
Date
Today (197)
Last 7 days (850)
Last 30 days (3066)
Last 365 days (36206)
2025 (5915)
2024 (37091)
2023 (41891)
2022 (53218)
2021 (57921)
2020 (56779)
2019 (50127)
2018 (38106)
2017 (35720)
2016 (35948)
2015 (42021)
2014 (35808)
2013 (32292)
2012 (33859)
2011 (33972)
2010 (33101)
Location
Africa (1122)
Alabama (55)
Alaska (7)
Arizona (205)
Arkansas (13)
Asia (47484)
Australia (8227)
California (5113)
Canada (1781)
China (441)
Colorado (239)
Connecticut (258)
Delaware (117)
Europe (105776)
Florida (758)
Georgia (176)
Idaho (59)
Illinois (519)
India (22)
Indiana (280)
Iowa (7)
Japan (130)
Kansas (105)
Kentucky (25)
Louisiana (10)
Maine (63)
Maryland (813)
Massachusetts (3984)
Michigan (221)
Minnesota (362)
Mississippi (2)
Missouri (76)
Montana (31)
Nebraska (26)
Nevada (56)
New Hampshire (67)
New Jersey (1458)
New Mexico (30)
New York (1467)
North Carolina (967)
North Dakota (8)
Northern California (2214)
Ohio (187)
Oklahoma (14)
Oregon (35)
Pennsylvania (1134)
Puerto Rico (7)
Rhode Island (22)
South America (1464)
South Carolina (14)
South Dakota (1)
Southern California (1918)
Tennessee (85)
Texas (748)
Utah (163)
Virginia (131)
Washington D.C. (60)
Washington State (506)
West Virginia (3)
Wisconsin (53)
773,161 Results for "ramot university authority for applied research and industrial development ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Press Releases
Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research
February 19, 2025
·
2 min read
Derm-Biome Pharmaceuticals and TransBIOtech awarded $450,000 Applied Research and Development (ARD) grant funding
Derm-Biome Pharmaceuticals, Inc is pleased to announce that, in partnership with TransBIOtech, is being awarded an Applied Research and Development grant via the College and Community Innovation program administered through the Natural Sciences and Engineering Council of Canada in collaboration with the Social Sciences and Humanities Research Council and the Canadian Institutes of Health Research.
May 8, 2024
·
1 min read
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
BioCapital
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland
Quoin Pharmaceuticals Ltd., a specialty pharmaceutical company focused on rare and orphan diseases, announced that it has signed a research agreement with The School of Pharmacy at University College Cork, Ireland.
June 12, 2024
·
5 min read
Business
Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding
Qu Biologics Inc. is pleased to announce, in partnership with TransBIOTech (Quebec), being awarded an Applied Research and Development (ARD) grant via the College and Community Innovation (CCI) program administered through the Natural Sciences and Engineering.
March 11, 2024
·
5 min read
Press Releases
Tempus Announces Collaboration With JW Pharmaceutical to Apply Real-World Data and Biological Modeling to Enhance Early Research and Development
October 28, 2024
·
5 min read
Genetown
SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford
SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases, announced a sponsored research agreement with The University of Oxford for the development of a vaccine against Epstein-Barr virus.
May 23, 2024
·
4 min read
Press Releases
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
November 5, 2024
·
6 min read
Drug Development
Diversity at the Forefront: Life Sciences Industry Champions Inclusive Representation
The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.
February 25, 2025
·
1 min read
·
Lori Ellis
1 of 77,317
Next
